Premium
P3‐128: COMBINATION OF BLOOD‐BASED BIOMARKERS AND NEUROPSYCHOLOGICAL ASSESSMENT ENABLES RELIABLE CLASSIFICATION OF TESTED SUBJECTS BY CONTROLS: MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
Author(s) -
Kleinschmidt Martin,
Schönfeld Robby,
Bittner Daniel,
Metzner Jürgen,
Leplow Bernd,
Demuth HansUlrich
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1217
Subject(s) - neuropsychology , cognition , dementia , neuroinflammation , medicine , disease , neurodegeneration , neuropsychological assessment , biomarker , alzheimer's disease , psychology , audiology , oncology , neuroscience , biology , biochemistry
Theo Stijnen, Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, Netherlands; 2 Gerontopole and INSERM UMR 1027, Toulouse, France; 3 Department of Medicine, Columbia University, New York, New York, United States; University of California San Francisco, San Francisco, California, United States; Leiden University Medical Center, Leiden, Netherlands. Contact e-mail: martijn.dewilde@nutricia.com